Step by Stepa HemeOncBuddy patient portal

Etoposide

Illustration: Etoposide

Say it: eh-TOE-poh-side · Brand names: Etopophos

Etoposide is a chemotherapy medicine that stops cancer cells from copying their genes.

What it is

Cells use a protein called topoisomerase 2 to cut and rejoin their genetic code (DNA). Etoposide blocks this protein, so the DNA stays broken. The cancer cell then dies.

Often used for

How you get it

Etoposide is usually given through a vein (IV) over 30 to 60 minutes. It is often given once a day for 3 to 5 days in a row, every 3 to 4 weeks. Some people take it as capsules instead. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Etoposide?
Etoposide is a chemotherapy medicine that stops cancer cells from copying their genes. Brand names: Etopophos.
What is Etoposide used for?
testicular cancer; small cell lung cancer; and sometimes lymphoma, leukemia, and other cancers.
How is Etoposide given?
Etoposide is usually given through a vein (IV) over 30 to 60 minutes. It is often given once a day for 3 to 5 days in a row, every 3 to 4 weeks. Some people take it as capsules instead. Your schedule may be different.
What are the common side effects of Etoposide?
Low blood counts. Hair loss. Upset stomach or throwing up. Not feeling hungry. Feeling tired. Mouth sores.
When should I call my care team while taking Etoposide?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Chills, a sore throat, a cough, or burning when you pee (signs of infection); Bleeding or bruising that is unusual for you; Feeling dizzy or faint during the infusion; Itching, rash, swelling of the face or lips, or trouble breathing during or soon after the infusion; Throwing up or diarrhea so bad you cannot keep fluids down.
Which chemotherapy plans include Etoposide?
BEAM, BEP, Carboplatin and etoposide, DA-EPOCH-R, RICE, VAC/IE, VIP.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.